Response to Comment on Laiteerapong et al. The Legacy Effect in Type 2 Diabetes: Impact of Early Glycemic Control on Future Complications (The Diabetes & Aging Study). Diabetes Care 2019;42:416-426
- PMID: 30679307
- PMCID: PMC6905479
- DOI: 10.2337/dci18-0036
Response to Comment on Laiteerapong et al. The Legacy Effect in Type 2 Diabetes: Impact of Early Glycemic Control on Future Complications (The Diabetes & Aging Study). Diabetes Care 2019;42:416-426
Comment on
-
The Legacy Effect in Type 2 Diabetes: Impact of Early Glycemic Control on Future Complications (The Diabetes & Aging Study).Diabetes Care. 2019 Mar;42(3):416-426. doi: 10.2337/dc17-1144. Epub 2018 Aug 13. Diabetes Care. 2019. PMID: 30104301 Free PMC article.
-
Comment on Laiteerapong et al. The Legacy Effect in Type 2 Diabetes: Impact of Early Glycemic Control on Future Complications (The Diabetes & Aging Study). Diabetes Care 2019;42: 416-426.Diabetes Care. 2019 Mar;42(3):e45. doi: 10.2337/dc18-1779. Epub 2019 Jan 24. Diabetes Care. 2019. PMID: 30679306 No abstract available.
References
-
- Hulman A, Bjerg L, Carstensen B. Comment on Laiteerapong et al. The legacy effect in type 2 diabetes: impact of early glycemic control on future complications (the Diabetes & Aging Study). Diabetes Care 2019;42:416–426 (Letter). Diabetes Care 2019;42:e45. DOI: 10.2337/dc18-1779 - PubMed
-
- UK Prospective Diabetes Study (UKPDS) Group Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998;352:854–865 - PubMed
-
- Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008;359:1577–1589 - PubMed
-
- Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology 1990;1:43–46 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
